<img src="https://ws.zoominfo.com/pixel/H4QRKGJNZm52yFBaHe9u" width="1" height="1" style="display: none;">

Decentralized Clinical Trials Readiness Assessment

Are you ready for decentralized clinical trials?

Decentralized clinical trials, powered by IoT for connected health, offer many benefits including simplified patient experience, improved quality of care, increased patient retention, and more accurate data. While this results in a positive impact on patient outcomes and faster time-to-market for critical new drugs, the process of sourcing, connecting, and managing mobile devices for hybrid or virtual trials may seem daunting for CROs and pharmaceutical companies.

Which clinical trials model is right for you?

The virtual clinical trials market is expected to grow at a CAGR of 12.6% between 2020 and 2027. Use this short decentralized clinical trials readiness assessment to determine if a traditional clinical trials model, hybrid approach, or fully virtual clinical trials model is right for you.